Pathophysiology News and Research

RSS

Study describes sequelae presenting more than six months after COVID-19 in non-hospitalized young adults

A recent study described COVID-19 sequelae developed in non-hospitalized young adults more than six months after COVID-19 infection.

15 Feb 2022

Progression of Alzheimer's disease is linked to oxidative brain damage, research confirms

Increased oxidative damage is linked to neurodegenerative disorders such as Alzheimer's disease (AD). Even though the pathophysiology of AD has been widely investigated, the likely relationship between mitochondrial dysfunction and the disease remains largely unknown.

14 Feb 2022

Mechanical clot removal may improve recovery after severe stroke in children

Serious disability was 6 times more likely to be the result three months after stroke among children whose clot-caused stroke in a large vessel (a type of ischemic stroke) was not treated with a procedure to extract the clot, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2022.

12 Feb 2022

Mechanical blood clot removal helps nearly half of stroke survivors to achieve good outcomes

Mechanical removal of blood clots reduced post-stroke disability in nearly half of "all-comer" real-world stroke patients in an international study, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2022.

11 Feb 2022

Direct oral anti-coagulants less likely to result in major bleeding after rare, fatal stroke

Direct oral anti-coagulant (anti-clotting) (DOAC) medications that target a single clotting factor work just as well to prevent future clots as the older, less-specific medication warfarin.

11 Feb 2022

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

If patients with clot-caused strokes obtain medical care more than 4½ hours after their symptoms are noticed, it is too late to receive the standard clot-busting medication alteplase.

11 Feb 2022

Mechanical clot removal may be effective and lead to better outcomes for stroke patients

Stroke patients previously considered unlikely to survive without severe disability may regain far more function if the blood clots (which cause an ischemic stroke) are mechanically removed in addition to standard medical therapy, according to preliminary late-breaking research presented today at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health, held in person in New Orleans and virtually, Feb. 9-11, 2022.

9 Feb 2022

Colchicine holds promise to reduce the risk of severe COVID-19

A recent article, published in Rheumatology and Therapy, reviews the potent evidence of colchicine against the SARS-CoV-2 infection.

7 Feb 2022

Study links COVID-19 inflammatory manifestations in brain lysates to Alzheimer’s Disease markers

In a new study, researchers investigated a link between the body’s inflammatory response to SARS-CoV-2 infection within the neuropathological pathways and tau hyperphosphorylation.

7 Feb 2022

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

Researchers in the United Kingdom have conducted an observational cohort study on hospitalized patients and have found that the degree of severity of acute coronavirus disease 2019 (COVID-19) predicts the occurrence of chronic cerebrovascular impairment. The study further suggests that the levels of cerebrovascular impairment are associated with worse cognitive, mental, and physical well-being.

7 Feb 2022

Dizziness is a common symptom of COVID-19

New research published in Internal and Emergency Medicine discusses the relationship between SARS-CoV-2 infection and dizziness.

6 Feb 2022

Hp-XeMRI identifies impaired gas transfer in lungs of non-hospitalised breathless Long-COVID patients with normal CT scans

Researchers have been investigating the symptoms and effect on the lungs in those who suffered from hospitalization due to COVID-19 but fully recovered and non-hospitalized sufferers of long-COVID.

4 Feb 2022

Scientists identify genome regions linked to migraine risk

An international consortium of leading migraine scientists identified more than 120 regions of the genome that are connected to risk of migraine.

3 Feb 2022

Older adults have greatest stroke risk in the first three days after COVID-19 diagnosis

The risk of stroke among older adults diagnosed with COVID-19 was highest within the first three days of diagnosis, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans and virtually, Feb. 8-11, 2022.

3 Feb 2022

Study examines the prevalence and predictors of food insecurity among stroke survivors

One in three stroke survivors in the U.S. have food insecurity, which is nearly double the prevalence among people who have not had a stroke, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans and virtually, Feb. 8-11, 2022.

3 Feb 2022

Taking steps to prevent heart attack may help slow cognitive decline

Preventing heart attacks may help slow cognitive decline, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans, and virtually, Feb. 8-11, 2022.

3 Feb 2022

Study shows a cause-and-effect link between cigarette smoking and cognitive impairment

The more people smoke, the worse they perform on cognitive tests, regardless of other health conditions known to affect cognition, according to preliminary research among adults aged 60 and older presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans, and virtually, Feb. 8-11, 2022.

3 Feb 2022

Brains of adults with heart-healthy lifestyle are larger and show fewer signs of injury, research finds

On imaging tests, brains were larger and showed fewer signs of injury in early to late middle-aged adults (ages 40-69 years) who had nearly ideal cardiovascular health, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans and virtually, Feb. 8-11, 2022.

3 Feb 2022

Prion-like domains in SARS-CoV-2 RBD and ACE2 play important functional roles in viral adhesion and entry

Scientists have recently detected and analyzed viral PrDs in the S protein of SARS-CoV-2, which are the novel regulators of virion assembly.

31 Jan 2022

Targeting CHI3L1 inhibits SARS-CoV-2 variants, including Delta and Omicron

Researchers show that the CHI3L1 inhibitors reduce epithelial cell infection by SARS-CoV-2 VOC pseudovirus moieties.

27 Jan 2022

Pathophysiology News and Research

Study describes sequelae presenting more than six months after COVID-19 in non-hospitalized young adults

Progression of Alzheimer's disease is linked to oxidative brain damage, research confirms

Mechanical clot removal may improve recovery after severe stroke in children

Mechanical blood clot removal helps nearly half of stroke survivors to achieve good outcomes

Direct oral anti-coagulants less likely to result in major bleeding after rare, fatal stroke

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

Mechanical clot removal may be effective and lead to better outcomes for stroke patients

Colchicine holds promise to reduce the risk of severe COVID-19

Study links COVID-19 inflammatory manifestations in brain lysates to Alzheimer’s Disease markers

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

Dizziness is a common symptom of COVID-19

Hp-XeMRI identifies impaired gas transfer in lungs of non-hospitalised breathless Long-COVID patients with normal CT scans

Scientists identify genome regions linked to migraine risk

Older adults have greatest stroke risk in the first three days after COVID-19 diagnosis

Study examines the prevalence and predictors of food insecurity among stroke survivors

Taking steps to prevent heart attack may help slow cognitive decline

Study shows a cause-and-effect link between cigarette smoking and cognitive impairment

Brains of adults with heart-healthy lifestyle are larger and show fewer signs of injury, research finds

Prion-like domains in SARS-CoV-2 RBD and ACE2 play important functional roles in viral adhesion and entry

Targeting CHI3L1 inhibits SARS-CoV-2 variants, including Delta and Omicron

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News